Identification and dynamics of a heparin-binding site in hepatocyte growth factor

被引:53
作者
Zhou, HJ
Casas-Finet, JR
Coats, RH
Kaufman, JD
Stahl, SJ
Wingfield, PT
Rubin, JS
Bottaro, DP
Byrd, RA [1 ]
机构
[1] NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Macromol NMR Sect, Frederick, MD 21702 USA
[2] NCI, AIDS Vaccine Program, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA
[3] NIAMSD, Prot Express Lab, Bethesda, MD 20892 USA
[4] NCI, Cellular & Mol Biol Lab, Div Basic Sci, Bethesda, MD 20892 USA
关键词
D O I
10.1021/bi9908641
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte growth factor (HGF) is a heparin-binding. multipotent growth factor that transduces a wide range of biological signals, including mitogenesis, motogenesis, and morphogenesis. Heparin or closely related heparan sulfate has profound effects on: HGF signaling. A heparin-binding site in the N-terminal (N) domain of HGF was proposed on the basis of the clustering of surface positive charges [Zhou, H., Mazzulla, M. J., Kaufman, J. D., Stahl, S. J., Wingfield, P. T., Rubin, J. S., Bottaro, D. P., and Byrd, R. A. (1998) Structure 6, 109-116]. In the present study, we confirmed this binding site in a heparin titration experiment monitored by nuclear magnetic resonance spectroscopy, and we estimated the apparent dissociation constant (Kd) Of the heparin-protein complex by NMR and fluorescence techniques. The primary heparin-binding site is composed of Lys60, Lys62, and Arg73, with additional contributions from the adjacent Arg76, Lys78, and N-terminal basic residues. The Kd Of binding is in the micromolar range. A heparin disaccharide analogue, sucrose octasulfate, binds with similar affinity to the N domain and to a naturally occurring HGF isoform, NK1, at nearly the same region as in heparin binding. N-15 relaxation data indicate structural flexibility on a microsecond-to-millisecond time scale around the primary binding site in the N domain. This flexibility appears to be dramatically reduced by ligand binding. On the basis of the NK1 crystal structure, we propose a model in which heparin binds to the two primary binding-sites and the N-terminal regions of the N domains and stabilizes an NK1 dimer.
引用
收藏
页码:14793 / 14802
页数:10
相关论文
共 46 条
[1]   Isolation and conformational analysis of fragment peptide corresponding to the heparin-binding site of hepatocyte growth factor [J].
Aoyama, H ;
Naka, D ;
Yoshiyama, Y ;
Ishii, T ;
Kondo, J ;
Mitsuka, M ;
Hayase, T .
BIOCHEMISTRY, 1997, 36 (33) :10286-10291
[2]  
ARAKAKI N, 1992, J BIOL CHEM, V267, P7101
[3]   IDENTIFICATION OF A COMPETITIVE HGF ANTAGONIST ENCODED BY AN ALTERNATIVE TRANSCRIPT [J].
CHAN, AML ;
RUBIN, JS ;
BOTTARO, DP ;
HIRSCHFIELD, DW ;
CHEDID, M ;
AARONSON, SA .
SCIENCE, 1991, 254 (5036) :1382-1385
[4]  
Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72
[5]   Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF scatter factor variant with partial agonist antagonist activity [J].
Cioce, V ;
Csaky, KG ;
Chan, AML ;
Bottaro, DP ;
Taylor, WG ;
Jensen, R ;
Aaronson, SA ;
Rubin, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :13110-13115
[6]   Structure of a heparin-linked biologically active dimer of fibroblast growth factor [J].
DiGabriele, AD ;
Lax, I ;
Chen, DI ;
Svahn, CM ;
Jaye, M ;
Schlessinger, J ;
Hendrickson, WA .
NATURE, 1998, 393 (6687) :812-817
[7]   Heparin structure and interactions with basic fibroblast growth factor [J].
Faham, S ;
Hileman, RE ;
Fromm, JR ;
Linhardt, RJ ;
Rees, DC .
SCIENCE, 1996, 271 (5252) :1116-1120
[8]   BACKBONE DYNAMICS OF A FREE AND A PHOSPHOPEPTIDE-COMPLEXED SRC HOMOLOGY-2 DOMAIN STUDIED BY N-15 NMR RELAXATION [J].
FARROW, NA ;
MUHANDIRAM, R ;
SINGER, AU ;
PASCAL, SM ;
KAY, CM ;
GISH, G ;
SHOELSON, SE ;
PAWSON, T ;
FORMANKAY, JD ;
KAY, LE .
BIOCHEMISTRY, 1994, 33 (19) :5984-6003
[9]   DUODENAL-ULCER - DISCOVERY OF A NEW MECHANISM AND DEVELOPMENT OF ANGIOGENIC THERAPY THAT ACCELERATES HEALING [J].
FOLKMAN, J ;
SZABO, S ;
STOVROFF, M ;
MCNEIL, P ;
LI, W ;
SHING, Y .
ANNALS OF SURGERY, 1991, 214 (04) :414-427
[10]   Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo [J].
Hartmann, G ;
Prospero, T ;
Brinkmann, V ;
Ozcelik, Ö ;
Winter, G ;
Hepple, J ;
Batley, S ;
Bladt, F ;
Sachs, M ;
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E .
CURRENT BIOLOGY, 1998, 8 (03) :125-134